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A century ago, Gertrude Stein told us
that a rose is a rose is a rose, but today,
modern genomics is telling us that a
pathogen is not a pathogen. Advances
in pathogenomics have greatly elucidated
the genetic and molecular underpinnings
of bacterial virulence and pathogene-
sis. This new knowledge of the evolu-
tion of pathogenic bacteria, and of the
ways by which they acquire and main-
tain virulence, has increasingly indicated
that not all bacterial pathogens are cre-
ated equal. Evolutionarily speaking, there
seem to be at least two broad categories
of pathogenic bacteria: obligate pathogens
that have evolved over time to become irre-
versibly specialized parasites and “Jekyll-
and-Hyde pathogens,” still closely related
to free-living bacteria, that have been
rapidly but reversibly made pathogenic
by mobile genetic elements. This distinc-
tion between full-scale genetic re-wiring
and subtle genetic fine-tuning represents a
fundamental contrast that may shed light
on the past, present, and future evolution
of pathogenic bacteria. More importantly,
we might be able to use this knowl-
edge of the paradigms of pathogenesis
to develop novel strategies for combating
some of today’s most significant bacterial
pathogens.
With the tremendous amount of infor-
mation that has been generated by the
genomics revolution, it is not surpris-
ing that new paradigms for the evolu-
tion of bacterial pathogens have emerged.
One such paradigm is that bacteria can
be pathogenic not because they possess
defined “virulence factors” but because
they have deleted genes detrimental to
a pathogenic lifestyle (Maurelli et al.,
1998) and/or have lost metabolic and reg-
ulatory genes required for a free-living
state (Georgiades and Raoult, 2011). This
principle of reductive evolution, which
posits that certain bacteria gain virulence
via massive gene deletion associated with
increased specialization, has been most
extensively documented amongst obli-
gate intracellular pathogens and seems to
represent a dominant evolutionary phe-
nomenon of particularly specialized bac-
teria (Merhej et al., 2009). Nevertheless,
massive gene loss is only a part of a larger
picture for many other pathogenic bac-
teria. In fact, certain bacterial pathogens
can be readily distinguished from non-
pathogenic, free-living kin not by massive
gene deletion but by specific virulence fac-
tors. Since non-pathogenic bacteria can
chromosomally encode certain structural
virulence factors previously considered
unique to pathogens, such as type III
and type VI secretion systems (Pallen and
Wren, 2007), it is important to empha-
size that the pathogenicity of these Jekyll-
and-Hyde bacteria is largely mediated by
mobile genetic elements such as bacterio-
phages and plasmids.
The most prominent examples of these
Jekyll-and-Hyde bacteria are those whose
virulence factors, typically exotoxins
and/or extracellular enzymes, are encoded
by temperate bacteriophages. Free-living
or commensal bacteria that pose little
threat to human health can be rapidly
transformed by lysogenic conversion into
aggressively virulent pathogens. For exam-
ple, uninfected strains of Clostridium
botulinum, Corynebacterium diphtheriae,
Escherichia coli, Staphylococcus aureus,
Streptococcus pyogenes, and Vibrio cholerae
are not usually dangerous, but those
lysogens that acquire just a few exoge-
nous genes from one or several virulence
factor-encoding bacteriophage(s) can
become highly virulent (Brussow et al.,
2004). In this light, one could even
make the case that the cholera toxin-
encoding bacteriophage CTXϕ, not the
bacterium V. cholerae, is the true causative
agent of the disease we know as cholera.
Similarly, a comparative genomic analy-
sis of three taxonomic species within the
genus Bacillus—B. anthracis, B. cereus, and
B. thuringiensis—suggests that these three
bacteria with vastly different ecological
niches (acute pathogen, ubiquitous soil
dweller, and insect commensal, respec-
tively) are genetically a single species
(Helgason et al., 2000). The genomes of
these three bacteria are of similar sizes, and
massive gene deletion does not explain
B. anthracis’s extreme virulence com-
pared to its kin; instead, its pathogenicity
is largely a product of certain virulence
factors encoded by two plasmids, with-
out which anthrax is not fully virulent
(Helgason et al., 2000). In all of these
cases, the presence or absence of one or
more virulence factor-encoding prophages
and/or plasmids strongly influences their
carriers’ virulence and pathogenicity.
Of course, not all pathogenic bacteria
can be neatly categorized into two camps:
some pathogens, like Shigella spp., differ
from their free-living kin both by gene
deletion and by extrachromosomal vir-
ulence factors (Johnson, 2000). Indeed,
these two paradigms of pathogenesis—
gene deletion and the acquisition of
mobile genetic elements—are not nec-
essarily mutually exclusive because they
operate over different scales of evolution-
ary time. In contrast to the classical evolu-
tion of bacteria, which occurs over many
thousands and millions of years, hori-
zontal gene transfer represents the fast
mode of evolution, one by which prokary-
otes can acquire new genes conferring
unique traits, including virulence, in a very
short time (Brussow et al., 2004). There
are also undoubtedly other dynamics,
such as epigenetics, that play important
roles in the evolution and maintenance
of virulence (Casadesus and Low, 2006).
Nevertheless, it is important to recognize
that the pathogenic bacteria confronting
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us today have, in many cases, gained
pathogenicity through fundamentally dif-
ferent mechanisms. Despite their obvious
differences, V. cholerae and B. anthracis
are both examples of a larger evolution-
ary phenomenon: rather than becoming
pathogenic by losing the genes whose
loss would irreversibly separate them from
their free-living relatives, as do obligate
intracellular pathogens, Jekyll-and-Hyde
bacteria differ from their free-living rela-
tives, and are made pathogenic, primarily
by their mobile genetic elements.
What practical value does this distinc-
tion have? The fact that bacterial virulence
can sometimes be directly attributed to
mobile genetic elements has potentially
significant biomedical implications. If we
refine our focus to implicate those mobile
genetic elements as the underlying causes
of the diseases traditionally attributed to
their bacterial hosts, we open the door to
the possibility of novel therapeutics with
unique mechanisms of action. One partic-
ularly nefarious host is E. coli O157:H7,
an enteric pathogen linked to a number of
highly-publicized food recalls and whose
enterohemorrhagic Shiga-like (Stx) toxins
can cause kidney failure (hemolytic uremic
syndrome) and even death (Eppinger et al.,
2011). As a Jekyll-and-Hyde pathogen,
E. coliO157:H7 gainsmuch of its virulence
and toxicity from Stx-encoding bacterio-
phages (Smith et al., 2007).
Because stx is largely silent in the
lysogenic state, significant toxin produc-
tion (and harm to the patient) does not
occur unless the lysogen’s Stx prophage(s)
is/are induced (McGannon et al., 2010).
Therefore, a strategy to prevent, disrupt, or
otherwise disable Stx prophage induction
would represent an innovative approach
to addressing an important medical prob-
lem, one for which conventional antibi-
otic therapy is not always adequate or
even advisable. Unlike most other bac-
terial infections which can be aggres-
sively combatted with antibiotics, E. coli
0157:H7 infections pose a special chal-
lenge because the use of certain antibiotics
can cause prophage induction, increased
toxin production, and further harm to
the patient (Zhang et al., 2000). This
dynamic can be viewed as a biomedi-
cal hostage situation in which a terrorist
(E. coli O157:H7) is holding a number
of hostages (human cells) and has a dead
man’s switch (inducible Stx prophages)
as a defense against the weapons of law
enforcement (antibiotics). As with real-
world hostage situations, the special med-
ical challenge is to neutralize the microbial
terrorist without triggering the dead man’s
switch and blowing up the hostages. One
way to do this would be to disable the
dead man’s switch: having lost the abil-
ity to kill the hostages, the terrorist would
no longer pose a significant threat and
could be easily neutralized. The funda-
mental purpose of an anti-induction strat-
egy, then, would be to eliminate E. coli’s
ability to harm human cells by preventing
the activation of its toxin-producing genes.
Even though this anti-induction strat-
egy would not be directly bactericidal, it
might, by reducing bacterial toxin produc-
tion, lessen the risk of serious complica-
tions, such as hemolytic uremic syndrome,
that can result from E. coli O157:H7
infection. By defusing enterohemorrhagic
E. coli’s molecular dead man’s switch, a
sufficiently effective anti-induction strat-
egy might even enable traditional antibi-
otic therapy of E. coli O157:H7 infections:
without the specter of prophage induction
and toxin production, there would be lit-
tle reason to avoid the use of antibiotics to
combat these infections.
Thomas Edison famously said that
genius is 1% inspiration and 99% per-
spiration, and indeed, the most diffi-
cult part of any applied science is not
in the conceiving of new ideas but in
their implementation. How, then, might
an anti-induction strategy work in prac-
tice? One approach would be to utilize
specific molecules that reduce prophage
induction by eliminating in vivo induc-
ing agents. Some of the most significant
of these inducing agents are reactive oxy-
gen species (ROS), such as hydrogen per-
oxide, that are produced as part of the
innate immune response (Wagner et al.,
2001). As powerful oxidizing agents, ROS
decompose into free radicals, which can
cause DNA damage to bacteria and, con-
sequently, prophage induction. Therefore,
one possible anti-induction strategy might
involve molecules, such as the antiox-
idant glutathione (Liu et al., 2005),
that scavenge free radicals and thereby
decrease prophage induction. Other ROS
scavengers, such as the manganese com-
plexes found in Deinococcus radiodurans
(Daly et al., 2010), might possess similar
medical relevance.
Nevertheless, the molecular approach
to stopping prophage induction has its
limitations, even on a theoretical level. For
one, the natural balance between antiox-
idants and pro-oxidants is a fine one,
and because ROS and free radicals play
important roles not just within the innate
immune system but also in cell signaling
and other normal physiologies (Townsend
et al., 2003), it might prove detrimental
to intentionally disrupt that balance. More
importantly, the human body contains
a plethora of chemically-distinct induc-
ing agents, meaning that highly spe-
cific molecular approaches designed to
bind or inhibit individual inducing agents
(e.g., receptor mimics) would probably
be insufficiently comprehensive. To have
any significant therapeutic value, any anti-
induction molecule would need to prevent
induction by many different agents.
Another anti-induction strategy, based
on basic phage biology and fundamen-
tally different from any molecular-based
approach, can also be envisioned. During
normal conditions in E. coli, prophages are
largely stable in lysogeny because the genes
required for lytic growth are repressed
by the repressor protein CI (Svenningsen
et al., 2005). Because prophage induc-
tion only occurs when the concentration
of repressor becomes too low (Ptashne,
2006), it would seem logical to predict
that more repressor means less induc-
tion. Indeed, significant overexpression of
CI repressor has been shown to strongly
reduce prophage induction in E. coli
(Czyz et al., 2001). Further, the car-
riage of multiple prophages by an E.
coli lysogen has been shown to decrease
prophage induction and Stx production
(Serra-Moreno et al., 2008). If the pres-
ence of multiple prophages decreases
induction, and if repressor overproduc-
tion further decreases induction, then
in vivo overexpression of repressor by
temperate phage co-infection could rep-
resent an alternate anti-induction strat-
egy. For E. coli O157:H7, this might be
achieved through the use of temperate col-
iphages, heteroimmune to Stx-encoding
prophages, that have been genetically
modified to lack a lytic cassette and to
overexpress CI repressor. Importantly, this
anti-induction strategy would be both
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corrective (by preventing prophage induc-
tion in Stx lysogens) and protective (by
preventing commensal E. coli, not yet
infected by Stx phages, from becoming
toxinogenic during the latter stages of
infection). By lacking the genes neces-
sary for the lytic cycle, these modified
phages would not propagate themselves
beyond the initial infection and should not
significantly impact gut microbiota, but
as viral factories producing large quan-
tities of repressor, they might be able
to greatly reduce Stx prophage induc-
tion, Shiga toxin production, and entero-
hemorrhagic E. coli’s threat to human
health.
Needless to say, these approaches
are (for now) theoretical and would
require significant scientific validation,
not to mention regulatory approval,
but the fundamental idea of developing
anti-induction strategies remains com-
pelling because the prominent role of
prophage induction in bacterial patho-
genesis extends far beyond E. coliO157:H7
to include infections caused by bacteria
as varied as V. cholerae, C. diphtheriae,
S. aureus, and group A streptococci
(Wagner and Waldor, 2002; Cao et al.,
2012). This paradigm of pathogenesis
presents us with a powerful opportunity:
by specifically targeting prophages and
other mobile genetic elements, we might
be able to apply our knowledge of the evo-
lution of bacterial virulence to develop
outside-the-box treatments for the Jekyll-
and-Hyde pathogens that are significant
contributors to human disease.
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